1 – 21 of 21
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
(
- Contribution to journal › Article
- 2018
-
Mark
Gender differences in early systemic sclerosis patients : a report from the EULAR scleroderma trials and research group (EUSTAR) database
(
- Contribution to journal › Article
-
Mark
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study
(
- Contribution to journal › Article
-
Mark
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
(
- Contribution to journal › Article
- 2017
-
Mark
Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Mapping and predicting mortality from systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Treatment outcome in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study (ESOS)
(
- Contribution to journal › Article
-
Mark
Update of EULAR recommendations for the treatment of systemic sclerosis
(
- Contribution to journal › Article
- 2014
-
Mark
Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Immunochip analysis identifies multiple susceptibility Loci for systemic sclerosis.
(
- Contribution to journal › Article
- 2013
-
Mark
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
(
- Contribution to journal › Article
- 2012
-
Mark
A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations
(
- Contribution to journal › Article
-
Mark
Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis.
2012) In Journal of Rheumatology(
- Contribution to journal › Article
- 2011
-
Mark
The Functional Polymorphism 844 A>G in Fc{alpha}RI (CD89) Does Not Contribute to Systemic Sclerosis or Rheumatoid Arthritis Susceptibility.
(
- Contribution to journal › Article
-
Mark
Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis
(
- Contribution to journal › Letter
-
Mark
Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population.
(
- Contribution to journal › Article
-
Mark
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
(
- Contribution to journal › Article
- 2010
-
Mark
Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Study (EUSTAR).
(
- Contribution to journal › Article
-
Mark
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
(
- Contribution to journal › Article
- 2008
-
Mark
A large multicenter analysis of CTGF-945 promoter polymorphism does not confirm association with systemic Sclerosis susceptibility or phenotype
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.588-589(
- Contribution to journal › Published meeting abstract